Page last updated: 2024-10-27

fenofibrate and Anasarca

fenofibrate has been researched along with Anasarca in 5 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Research Excerpts

ExcerptRelevanceReference
"Fenofibrate did not inhibit mechanical allodynia or paw edema induced by phorbol-12,13-didecanoate (PDD), a protein kinase C activator, in rats."5.34Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma. ( Bertollo, CM; Coelho, MM; Costa, KA; Nascimento, EB; Oliveira, AC; Rocha, LT, 2007)
"Peroxisome proliferator-activated receptor (PPAR)-gamma ligand, pioglitazone (PIO), is reported to induce edema especially in postmenopausal women."3.74Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-gamma ligands in ovariectomized obese rats. ( Hasegawa, K; Hayashi, K; Homma, K; Ito, O; Kanda, T; Omata, K; Saruta, T; Sugano, N; Tatematsu, S; Wakino, S; Yoshioka, K, 2008)
"Fenofibrate did not inhibit mechanical allodynia or paw edema induced by phorbol-12,13-didecanoate (PDD), a protein kinase C activator, in rats."1.34Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma. ( Bertollo, CM; Coelho, MM; Costa, KA; Nascimento, EB; Oliveira, AC; Rocha, LT, 2007)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prasad, GS1
Govardhan, P1
Deepika, G1
Vakdevi, V1
Sashidhar, RB1
Oliveira, AC1
Bertollo, CM1
Rocha, LT1
Nascimento, EB1
Costa, KA1
Coelho, MM1
Stroup, JS1
Karalliedde, J1
Viberti, GC1
Yoshioka, K1
Wakino, S1
Homma, K1
Kanda, T1
Tatematsu, S1
Hasegawa, K1
Sugano, N1
Ito, O1
Omata, K1
Saruta, T1
Hayashi, K1

Other Studies

5 other studies available for fenofibrate and Anasarca

ArticleYear
Anti-inflammatory activity of anti-hyperlipidemic drug, fenofibrate, and its phase-I metabolite fenofibric acid: in silico, in vitro, and in vivo studies.
    Inflammopharmacology, 2018, Volume: 26, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Computer Simulation; Cyclooxygenase 1; Cyclooxygenas

2018
Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma.
    European journal of pharmacology, 2007, Apr-30, Volume: 561, Issue:1-3

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Disease Models, Animal; Dose-Response Re

2007
Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255.
    Diabetes, 2007, Volume: 56, Issue:5

    Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Edema; Fenofibrate; Humans; Hypoglycemic Agent

2007
Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255.
    Diabetes, 2007, Volume: 56, Issue:5

    Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Edema; Fenofibrate; Humans; Hypoglycemic Agent

2007
Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-gamma ligands in ovariectomized obese rats.
    Obesity (Silver Spring, Md.), 2008, Volume: 16, Issue:5

    Topics: Animals; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Dinoprostone; Disease Models, Anima

2008